Ohio State is in the process of revising websites and program materials to accurately reflect compliance with the law. While this work occurs, language referencing protected class status or other activities prohibited by Ohio Senate Bill 1 may still appear in some places. However, all programs and activities are being administered in compliance with federal and state law.

Sorafenib and Mek inhibition is synergistic in medullary thyroid carcinoma in vitro

Sorafenib and Mek inhibition is synergistic in medullary thyroid carcinoma in vitro

Investigators

Yoon Woo Koh
Manisha H Shah
Kitty Agarwal
Samantha K McCarty
Bon Seok Koo
Victoria J Brendel
Chaojie Wang
Kyle Porter
David Jarjoura
Motoyasu Saji
Matthew D Ringel

Filters: 2012